Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
The Multiple Sclerosis Drug Fingolimod Induces Pore-Like Membrane Defects, Contributing to Its Antimicrobial Activity.
Associations between perfluoroalkyl substances and multiple sclerosis in U.S. cohorts compared with NMOSD, MOGAD, and healthy controls.
Ketogenic diet improves motor and anxiety-like behaviors plus cerebellar inflammation via axonal remyelination in the BTBR mouse model of autism.
Rare adverse events after COVID-19 vaccination among Swedish older adults-evidence from a nationwide register-based study.
A multilevel linguistic analysis reveals linguistic impairments in persons with multiple sclerosis.
IGFBP7 in multiple sclerosis: A marker of compartmentalized inflammation with limited diagnostic specificity.
No evidence for a causal link between plasma lipids and multiple sclerosis susceptibility and severity: A Mendelian randomisation study.
Aging beyond diagnosis: the MRI brain age gap across disorders.
Bilateral fuchs uveitis syndrome and its association with multiple sclerosis.
Diagnostic and prognostic value of blood neurofilament light chain in ischemic stroke: an individual patient data meta-analysis.
The evolution of CAR therapies across oncology and autoimmunity: mechanistic insights and therapeutic innovations.
A novel limited-dose C5 inhibitor add-on as rescue therapy for refractory NMOSD attacks: a practical alternative to conventional multi-dose regimens.
The relationship between objective and subjective cognitive performance and clinical and MRI disease burden in early multiple sclerosis.
Pages
« first
‹ previous
…
971
972
973
974
975
976
977
978
979